Type I interferons and the innate immune response--more than just antiviral cytokines - PubMed (original) (raw)
Review
Type I interferons and the innate immune response--more than just antiviral cytokines
Peter L Smith et al. Mol Immunol. 2005 May.
Abstract
The role of type I interferon (referred to as IFN in this review) in early antiviral immunity is well known. More recently IFN has been shown to be a potent regulator of adaptive immunity. It is now becoming clear that a broad range of viruses, bacteria and even parasites express ligands capable of stimulating a growing number of signalling pathways that results in, often subtype specific, induction of IFN. Of particular interest are the signalling pathways associated with the Toll-like receptors. This family of receptors, each able to induce signals in response to a variety of ligands, initiates the pro-inflammatory response. They also contain members that have the capacity to induce IFN, making use of, and perhaps promoting the evolution of its pleiotropic responses. Greater knowledge of the events that result in induction of IFN is necessary in understanding the specificity of expression of an increasingly complex and important aspect of our immune system. This may reveal to us further therapeutic opportunities, either in the use of IFN or in the manipulation of their expression. This review details the established knowledge and recent advances made in understanding how and under what circumstances the IFNs are expressed, starting with brief overviews of IFN and Toll-like receptors before following the molecular processes from induction of IFN, activation of the JAK-STAT pathway and finally the expression of interferon stimulated genes and their functions.
Similar articles
- Mechanisms of type I interferon signaling in normal and malignant cells.
Li Y, Srivastava KK, Platanias LC. Li Y, et al. Arch Immunol Ther Exp (Warsz). 2004 May-Jun;52(3):156-63. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15247882 Review. - Zebrafish larvae are unable to mount a protective antiviral response against waterborne infection by spring viremia of carp virus.
López-Muñoz A, Roca FJ, Sepulcre MP, Meseguer J, Mulero V. López-Muñoz A, et al. Dev Comp Immunol. 2010 May;34(5):546-52. doi: 10.1016/j.dci.2009.12.015. Epub 2010 Jan 7. Dev Comp Immunol. 2010. PMID: 20045026 - Innate immune response to viral infection.
Koyama S, Ishii KJ, Coban C, Akira S. Koyama S, et al. Cytokine. 2008 Sep;43(3):336-41. doi: 10.1016/j.cyto.2008.07.009. Epub 2008 Aug 9. Cytokine. 2008. PMID: 18694646 Review. - Pathogen recognition with Toll-like receptors.
Kawai T, Akira S. Kawai T, et al. Curr Opin Immunol. 2005 Aug;17(4):338-44. doi: 10.1016/j.coi.2005.02.007. Curr Opin Immunol. 2005. PMID: 15950447 Review. - Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G. Oganesyan G, et al. Nature. 2006 Jan 12;439(7073):208-11. doi: 10.1038/nature04374. Epub 2005 Nov 23. Nature. 2006. PMID: 16306936
Cited by
- Antagonistic roles of cGAS/STING signaling in colorectal cancer chemotherapy.
Liang B, Xing X, Storts H, Ye Z, Claybon H, Austin R, Ding R, Liu B, Wen H, Miles WO, Fishel R, Wang JJ. Liang B, et al. Front Oncol. 2024 Oct 14;14:1441935. doi: 10.3389/fonc.2024.1441935. eCollection 2024. Front Oncol. 2024. PMID: 39469633 Free PMC article. - A Critical Analysis of the FDA's Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity.
Niazi SK. Niazi SK. Pharmaceuticals (Basel). 2023 Nov 2;16(11):1556. doi: 10.3390/ph16111556. Pharmaceuticals (Basel). 2023. PMID: 38004421 Free PMC article. Review. - Dynamic immune markers predict HIV acquisition and augment associations with sociobehavioral factors for HIV exposure.
Bender Ignacio RA, Dasgupta S, Valdez R, Pandey U, Pasalar S, Alfaro R, Hladik F, Gornalusse G, Lama JR, Duerr A. Bender Ignacio RA, et al. iScience. 2022 Nov 19;25(12):105632. doi: 10.1016/j.isci.2022.105632. eCollection 2022 Dec 22. iScience. 2022. PMID: 36483014 Free PMC article. - The protein arginine methyltransferase PRMT9 attenuates MAVS activation through arginine methylation.
Bai X, Sui C, Liu F, Chen T, Zhang L, Zheng Y, Liu B, Gao C. Bai X, et al. Nat Commun. 2022 Aug 26;13(1):5016. doi: 10.1038/s41467-022-32628-y. Nat Commun. 2022. PMID: 36028484 Free PMC article. - Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer.
Ebersbach C, Beier AK, Thomas C, Erb HHH. Ebersbach C, et al. Cancers (Basel). 2021 Sep 28;13(19):4854. doi: 10.3390/cancers13194854. Cancers (Basel). 2021. PMID: 34638338 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources